Pharma D Solutions voluntarily recalls all sterile compounded drugs

All sterile compounded drug products from Pharma D Solutions are being voluntarily recalled due to a potential contamination risk at the pharmacy, according to a company press release.

The drugs affected by the recall include any compounded at the pharmacy within the past 12 months, which were distributed nationwide and directly to customers and medical facilities. It does not include non-sterile compounded products made at Pharma D Solutions.

A routine FDA inspection of the facility prompted the voluntary recall; however, no medications or components have been found to be non-sterile, and no adverse events or patient complaints have been received.

“This voluntary recall is being conducted out of an abundance of caution and to promote patient safety, which is the pharmacy’s highest priority,” the release said.

All sterile compounded drug products from Pharma D Solutions are being voluntarily recalled due to a potential contamination risk at the pharmacy, according to a company press release.

The drugs affected by the recall include any compounded at the pharmacy within the past 12 months, which were distributed nationwide and directly to customers and medical facilities. It does not include non-sterile compounded products made at Pharma D Solutions.

A routine FDA inspection of the facility prompted the voluntary recall; however, no medications or components have been found to be non-sterile, and no adverse events or patient complaints have been received.

“This voluntary recall is being conducted out of an abundance of caution and to promote patient safety, which is the pharmacy’s highest priority,” the release said.